
The Competition Authority has published its decision. No. 29/2016, The Landspítali's procurement of medical products – the importance of competition in public procurement. The decision describes the Competition Authority's investigation into Landspítali's procurement of medical devices and other healthcare products, and indications of the hospital's competition-restrictive conduct in connection with them. The investigation was prompted by a complaint from Logaland ehf, a healthcare service company that sells medical products, including medical devices, nursing supplies and nursing equipment.
The decision, which is now being published, outlines significant changes to the Landspítali's procurement procedures. They are designed to permanently strengthen competition in the market for healthcare products in Iceland, for the benefit of the public, Landspítali and competitors in the market. The measures remove the barriers to competition that the Competition Authority identified during its handling of the case. An annex to the decision publishes Landspítalans' formal declaration of these measures.
The above measures were developed in discussions between the Competition Authority and Landspítalinn. The Competition Authority, among other things, made observations on the procurement of goods that are exempt from the obligation to tender, procurement using charitable funds, the use of subjective tendering criteria, the implementation of framework agreements and the hospital's communications with suppliers. The Competition Authority also proposed specific solutions that could be implemented to improve procurement and thereby competition in the relevant markets.
During its investigation of the case, the Competition Authority took a position on whether there were grounds to impose binding intervention on Landspítalinn. The authority's conclusion is that, in light of the circumstances of the case, there are no grounds for applying either the prohibition provisions of the Competition Act or the provisions of the Competition Act that permit action in respect of conduct by public bodies which has an adverse effect on competition. This conclusion is based, among other things, on considerations regarding the scope of the Competition Act, the overlap in the roles of the supervisory authority and the Procurement Appeals Board, and the measures that Landspítali has taken.
The actions of the National University Hospital to promote competition in the trade of healthcare products are as follows:
The declaration is further elaborated in the decision of the Competition Authority.
Páll Gunnar Pálsson, Director-General of the Competition Authority:
„The National University Hospital is one of the largest public sector purchasers of goods and services. In the view of the Competition Authority, it is extremely important that competition is considered when conducting public tenders. Well-designed tenders that ensure effective competition can achieve considerable savings and efficiencies in public sector operations. In connection with this matter, Landspítali has undertaken reforms to its procurement practices with this in mind.“
"*" indicates required fields